Incarceration associated with higher cancer mortality, Yale study shows

New research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with cancer in the first year after release from prison.The findings were published today in the journal PLOS...
16-Sep-2022 2:40 PM EDT Add to Favorites

ADAURA Trial Results Provide New Hope for Patients with Early-Stage Non-Small Cell Lung Cancer

Newly released results from the Phase III ADAURA trial reveal that osimertinib yielded a 5.5-year median disease-free survival in the post-surgical treatment of patients with EGFR-mutated lung cancer, and nearly three in four patients treated with...
12-Sep-2022 9:35 AM EDT Add to Favorites

For Medicaid-Insured Patients with Cancer, Health Insurance Does Not Always Mean Health Access

Although there has been a significant increase in the number of U.S. residents insured through Medicaid since the expansion of the Patient Protection and Afforadble Care Act (ACA) in March 2010, the ability of Medicaid-insured patients to access...
15-Jul-2022 1:30 PM EDT Add to Favorites

New Research on Colorectal Cancer

Michael Cecchini, MD, recently received a K08 grant from the NCI to conduct research aimed at investigating multiple clinical trials for patients with colorectal cancer. The first trial is a Phase II study in which patients will be treated with a...
13-Jul-2022 1:35 PM EDT Add to Favorites

Defining the Landscape of Prostate Cancer Treatment

Smilow Cancer Hospital is now offering a new surgical option for prostate cancer treatment unavailable elsewhere in Connecticut, and still rare throughout the United States. The beneficiaries are men in need of a prostatectomy, a procedure in which...
11-Jul-2022 9:50 AM EDT Add to Favorites

Bold Plans for Cancer Care at Yale

Eric Winer, MD, began his tenure at Yale in February 2022 with a vision to expand the cancer program and national prominence of Yale Cancer Center and Smilow Cancer Hospital. He is already recruiting more physicians and researchers and focusing on...
6-Jul-2022 11:05 AM EDT Add to Favorites

Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer

Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy...
20-May-2022 9:45 AM EDT Add to Favorites

Treatment Efficacy Score a Better Way to Predict Long-Term Survival in Breast Cancer Trials

In a study led by Dr. Lajos Pusztai, Professor of Medicine (Medical Oncology) at Yale Cancer Center, researchers across various institutions, and on behalf of the I-SPY consortium, developed a novel continuous residual cancer based metric to compare...
10-May-2022 10:05 AM EDT Add to Favorites